This ad will auto close in 10 seconds

Orchid gets USFDA approval for Alzheimer tablets

Last Updated: Friday, January 8, 2010 - 12:55

Mumbai: Pharma company Orchid Chemicals & Pharmaceuticals today said it has received approval from US drug regulator for Memantine Hydrochloride tablets used in the treatment of Alzheimer disease.
The company has received a tentative approval from US
Food and Drug Administration (USFDA) for its abbreviated new drug application Memantine Hydrochloride tablets, Orchid Chemicals said in a filing to the Bombay Stock Exchange.
The tablets are available in 5 mg and 10 mg strengths.


First Published: Friday, January 8, 2010 - 12:55
comments powered by Disqus